
Pictured from L-R: Priscilla Do, PhD; Lacey Perdue, BS; Biaggio Uricoli, BS; Frankie, JD; Erik Dreaden, PhD; James Kelvin, MS; Andy Chyong; Emma Costanza. Not pictured: Juhi Jain, MD.
“Research in the Dreaden Lab focuses on the development of therapeutic technologies for both adults and children with cancer. In particular, their research exploits nanometer-scale materials and engineered polymers as a means to impart non-natural and improved function to cancer therapies and immunotherapies. Current areas of research include light-induced immune modulation, therapeutic T cell redirection, and tumor-targeted drug cocktail formulations.”